insights_auto
Why is MRNA up 14,21%?
Dive Deeperchevron_right
MRNA:NASDAQ
Moderna Inc
225,00 USD
arrow_upward
+14,21%(+28,00) 1D
225,47 USD
arrow_upward
+0,21% (+0,47)bedtimeAfter hours
Closed: 9-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
199,00 USD
High
225,00 USD
Low
197,17 USD
Mkt. cap
89,83 млд
Avg. vol.
16,88 млн
Volume
28,95 млн
52-wk high
225,00 USD
52-wk low
22,29 USD
EPS
-7,98 USD
Beta
1,09
Shares outstanding
399,24 млн
No. of employees
5 миң
Open
199,00 USD
High
225,00 USD
Low
197,17 USD
Mkt. cap
89,83 млд
Avg. vol.
16,88 млн
Volume
28,95 млн
52-wk high
225,00 USD
52-wk low
22,29 USD
EPS
-7,98 USD
Beta
1,09
Shares outstanding
399,24 млн
No. of employees
5 миң
News stories
From web sources and news partners
JournalArta
·
56 мүнөт мурун
Covid vaccine stock S&P leader surges: What to Know
Yahoo Finance
·
5 саат мурун
Moderna (MRNA) Stock Sees Modest Fair Value Lift After Cancer Vaccine Analyst Revisions
Simply Wall Street
·
7 саат мурун
Moderna Stock Surge Puts These Oncology Biotechs On Retail Investors Radar
The Motley Fool
·
17 саат мурун
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc